Zenas BioPharma, Inc. (ZBIO) valuation

Share price $19.55 · As of last filing 2026-03-31

Price-to-Earnings

P/E · Trailing Diluted

-2.15×

P/E history →

Price-to-Free-Cash-Flow

P/FCF · Trailing

-5.86×

P/FCF history →

Free-Cash-Flow Yield

FCF Yield · Trailing

-17.05%

FCF Yield history →

Enterprise-Value-to-EBITDA

EV/EBITDA · Trailing

-1.17×

EV/EBITDA history →

Underlying EBIT Margin

EBIT + SBC · Trailing

-1309.74%

Methodology →

Price-to-Sales

P/S · Trailing

41.14×

P/S history →

Price-to-Book

P/B · Latest filing

3.68×

P/B history →

Special situation detected — historical normalisation may not reflect go-forward economics. EPV and Reverse-DCF outputs below are anchored on history that no longer represents the entity going forward (net cash > 50% of market cap) . Inspect the balance sheet, recent 8-K filings, and the cards above before relying on these models.

net cash > 50% of market cap. Net cash $740.8M (cash $935.5M − debt $194.7M) = 60.0% of market cap $1.23B

Related tickers

NTHI

NEONC TECHNOLOGIES HOLDINGS, INC.

WM

Waste Management, Inc

ELWT

Elauwit Connection, Inc.